<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04599348</url>
  </required_header>
  <id_info>
    <org_study_id>PAN-HRG80-2020</org_study_id>
    <nct_id>NCT04599348</nct_id>
  </id_info>
  <brief_title>Treatment of CFS and Fibromyalgia With HRG 80 Red Ginseng</brief_title>
  <official_title>Treatment of CFS and Fibromyalgia With HRG 80 Red Ginseng</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Practitioners Alliance Network</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Practitioners Alliance Network</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Will a unique form of ginseng be clinically helpful in those with chronic fatigue syndrome&#xD;
      and fibromyalgia?&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Ginseng has been shown in earlier studies to help fatigue in a number of conditions. But&#xD;
      because of overharvesting, most ginseng is no longer have optimal levels of the active&#xD;
      ginsenosides. A new technique has been developed to restore the level of active ginseng&#xD;
      components those found in the wild ginseng used in earlier studies. This is available in a&#xD;
      form called HRG 80 Red Ginseng.&#xD;
&#xD;
      The study is an open pilot study to explore whether this treatment would be helpful for&#xD;
      improving clinical function and symptomatology in chronic fatigue syndrome and fibromyalgia.&#xD;
      Current clinical experience is suggesting that it may be.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 14, 2020</start_date>
  <completion_date type="Anticipated">April 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2021</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Open label study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Composite Visual analog scale of symptoms</measure>
    <time_frame>6 weeks</time_frame>
    <description>Composite Score visual analog scale (0 - 30 Visual analog scale units , with 30 VAS units representing optimal function) of energy, cognition, and overall well-being. Each on a 0-10 scale with 10 being healthy. The units are the same for all 3 allowing them to be combined into a single composite total score. This total score (0-30 with 30 being the best outcome ) is the primary outcome measure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>VAS of pain and sleep</measure>
    <time_frame>6 weeks</time_frame>
    <description>VAS of pain and sleep</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Fibromyalgia</condition>
  <condition>CFS</condition>
  <arm_group>
    <arm_group_label>Active Ginseng treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>People with CFS or Fibromyalgia will receive HRG 80 Red GInseng</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>HRG 80 Red Ginseng</intervention_name>
    <description>A unique form of ginseng with the high level of active ginseng components similar to those found in the wild ginseng used in earlier studies.</description>
    <arm_group_label>Active Ginseng treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. be diagnosed with CFS and/or fibromyalgia&#xD;
&#xD;
          2. live in the United States 3 - be over 18 years of age&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jacob Teitelbaum</last_name>
    <role>Principal Investigator</role>
    <affiliation>FFTF LLC</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jacob Teitelbaum, MD</last_name>
    <phone>4105627409</phone>
    <email>FatigueDoc@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Kona Research Center</name>
      <address>
        <city>Kailua</city>
        <state>Hawaii</state>
        <zip>96740</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacob Teitelbaum</last_name>
      <phone>410-562-7409</phone>
      <email>FatigueDoc@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 15, 2020</study_first_submitted>
  <study_first_submitted_qc>October 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 22, 2020</study_first_posted>
  <last_update_submitted>October 21, 2020</last_update_submitted>
  <last_update_submitted_qc>October 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Practitioners Alliance Network</investigator_affiliation>
    <investigator_full_name>Jacob Teitelbaum</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <keyword>Ginseng</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibromyalgia</mesh_term>
    <mesh_term>Myofascial Pain Syndromes</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

